About the Product

Description


Mirtafoam 30 Tablet containing Mirtazapine is used for the management of depressive and mood disorders under medical supervision. It helps support emotional balance and mental well-being.

Mirtazapine works by regulating neurotransmitter activity in the brain, thereby helping improve mood and manage symptoms associated with depressive disorders.

The tablet is widely prescribed in psychiatric practice for long-term mental health management, leading to consistent prescription-based demand.

With increasing awareness of mental health care and demand for effective antidepressant therapies, this product offers strong business potential for authorized distributors and healthcare suppliers. Its broad clinical relevance, established therapeutic role, and steady prescription demand make it a reliable product for growth in the neuropsychiatric segment.

Some patients may experience drowsiness, increased appetite, weight gain, dry mouth, dizziness, or constipation. Rarely, severe mood changes, low blood cell counts, or allergic reactions may occur and require medical attention.

Mirtafoam 30 Tablet is indicated for depression, anxiety associated with depression, sleep disturbances related to mood disorders, and loss of appetite in depressive conditions. It helps improve mood, reduce anxiety, promote restful sleep, and enhance emotional stability.

This medicine should be used strictly under medical supervision. Avoid alcohol and activities requiring mental alertness until the medicine’s effects are known. Sudden discontinuation should be avoided without medical advice.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Mirtafoam 30 Tablet in the PCD pharma franchise market?

Mirtafoam 30 Tablet, containing Mirtazapine 30mg, has strong demand in the psychiatry and neurocare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on mental health, depression, and CNS care portfolios.

Why should medical distributors include Mirtafoam 30 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for antidepressant therapy used in depression, anxiety disorders, sleep disturbances, and appetite-related conditions. Mirtazapine-based formulations are widely prescribed, helping strengthen a comprehensive psychiatry product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Mirtafoam 30 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Mirtafoam 30 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Mirtafoam 30 Tablet distribution?

Wholesalers and medical agencies benefit from steady psychiatric prescription demand, long-term therapy usage, reliable supply chain support, and good margins when partnering for Mirtafoam 30 Tablet distribution.

How can I become a distributor or franchise partner for Mirtafoam 30 Tablet?

Medical distributors, stockists, and wholesalers interested in Mirtafoam 30 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.